NCT04249245View on ClinicalTrials.gov

Role of Nasal Dysbiosis in Parkinson Disease

CompletedOBSERVATIONAL

Enrollment

285

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

April 25, 2024

Study Completion Date

April 25, 2024

Conditions

Parkinson Disease

Interventions

OTHER

Nasal Swab

All

Trial Locations (2)

75013

Pitie-Salpetriere Hospital, Paris

Unknown

Centre Hospitalier Universitaire, Pointe-à-Pitre

Sponsors

Lead Sponsor

Institut Pasteur

All Listed Sponsors

lead

Institut Pasteur

INDUSTRY

NCT04249245 - Role of Nasal Dysbiosis in Parkinson Disease | Biotech Hunter | Biotech Hunter